<DOC>
	<DOCNO>NCT00928577</DOCNO>
	<brief_summary>Primary Objectives : - To compare rate myopericarditis ( subclinical , suspect , probable , confirm ) deploy military subject receive ACAM2000® vaccine rate among subject position deploy would personally eligible receive ACAM2000 vaccine receive ACAM2000 vaccine due recency prior vaccination ( determine DoD healthcare provider ) due condition characteristic contact . - To identify case subclinical myopericarditis deploy military subject receive ACAM2000 vaccine . Secondary Objectives : - To compare rate severe serious dermatologic adverse event observe deploy military subject receive ACAM2000® vaccine rate among subject position deploy would personally eligible receive ACAM2000 vaccine receive ACAM2000 vaccine due recency prior vaccination ( determine DoD healthcare provider ) due condition characteristic contact . - To compare rate severe serious neurological adverse event observe deploy military subject receive ACAM2000® vaccine rate among subject position deploy would personally eligible receive ACAM2000 vaccine receive ACAM2000 vaccine due recency prior vaccination ( determine DoD healthcare provider ) due condition characteristic contact . - To compare rate adverse event observed subject approximately 10 day follow ACAM2000® vaccination rate among subject position deploy would personally eligible receive ACAM2000 vaccine receive ACAM2000 vaccine due recency prior vaccination ( determine DoD healthcare provider ) due condition characteristic contact . - To evaluate potential risk factor associate development confirmed , probable , and/or suspect ACAM2000-associated myopericarditis .</brief_summary>
	<brief_title>Safety Surveillance Cohort Study Vaccinia Vaccine ( ACAM2000® )</brief_title>
	<detailed_description>This prospective safety surveillance study US military Department Defense ( DoD ) population . Military subject either naive smallpox immunization receive ACAM2000® vaccine previously immunize vaccinia vaccine , usually Dryvax® , enrol study . No vaccine administer part study .</detailed_description>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Written inform consent obtain prior conduct studyrelated procedure . Male Female military personnel position active deployment . Participant naïve previous smallpox vaccination receive ACAM2000 vaccine ( Cohort 1 ) , OR , Participant receive ACAM2000 vaccine within prior 3 year , AND ineligible current ACAM2000 vaccination either recency prior vaccinia vaccination reason solely attributable condition characteristic contact ( healthy soldier marry someone contraindicate condition ) ( Cohort 2 ) . Exclusion Criteria : Subjects judge investigator unlikely understand scope study and/or unlikely able compliant study procedures visit . Participation study involve investigational market product within 30 day prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Smallpox</keyword>
	<keyword>Smallpox Vaccine</keyword>
	<keyword>Vaccinia virus</keyword>
	<keyword>Military</keyword>
</DOC>